News Releases
Keyword Search
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
Date Title  
02/21/18 Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roivant Sciences Printer Friendly Version
02/20/18 Avid Bioservices Announces Closing of Public Offering of Common Stock Printer Friendly Version
02/15/18 Avid Bioservices Announces Pricing of Public Offering of Common Stock Printer Friendly Version
02/14/18 Avid Bioservices Announces Proposed Offering of Common Stock Printer Friendly Version
02/12/18 Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including Bavituximab Printer Friendly Version
01/23/18 Avid Bioservices to Present at NobleCon14 Printer Friendly Version